Ngā hua rapu - Von, Thanh
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
-
2
PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition mā Spangle, Jennifer M., Von, Thanh, Pavlick, Dean C., Khotimsky, Arina, Zhao, Jean J., Roberts, Thomas M.
I whakaputaina 2020Text -
3
Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome mā Wang, Qi, Von, Thanh, Bronson, Roderick, Ruan, Minzi, Mu, Wenxia, Huang, Alan, Maira, Sauveur-Michel, Zhao, Jean J.
I whakaputaina 2013Text -
4
NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K–AKT and JAK–STAT3 pathways mā Yuzugullu, Haluk, Von, Thanh, Thorpe, Lauren M, Walker, Sarah R, Roberts, Thomas M, Frank, David A, Zhao, Jean J
I whakaputaina 2016Text -
5
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers mā Wang, Qi, Liu, Pian, Spangle, Jennifer M., Von, Thanh, Roberts, Thomas M., Lin, Nancy U., Krop, Ian E., Winer, Eric P., Zhao, Jean J.
I whakaputaina 2015Text -
6
Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anti-cancer agent mā Ni, Jing, Liu, Qingsong, Xie, Shaozhen, Carlson, Coby B., Von, Thanh, Vogel, Kurt W., Riddle, Steve M., Benes, Cyril H., Eck, Michael J., Roberts, Thomas M, Gray, Nathanael S., Zhao, Jean J.
I whakaputaina 2012Text -
7
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α mā Gritsman, Kira, Yuzugullu, Haluk, Von, Thanh, Yan, Howard, Clayton, Linda, Fritsch, Christine, Maira, Sauveur-Michel, Hollingworth, Gregory, Choi, Christine, Khandan, Tulasi, Paktinat, Mahnaz, Okabe, Rachel O., Roberts, Thomas M., Zhao, Jean J.
I whakaputaina 2014Text -
8
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells mā Wang, Yubao, Lee, Young-Mi, Baitsch, Lukas, Huang, Alan, Xiang, Yi, Tong, Haoxuan, Lako, Ana, Von, Thanh, Choi, Christine, Lim, Elgene, Min, Junxia, Li, Li, Stegmeier, Frank, Schlegel, Robert, Eck, Michael J, Gray, Nathanael S, Mitchison, Timothy J, Zhao, Jean J
I whakaputaina 2014Text -
9
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer mā Wang, Yubao, Zhang, Tinghu, Kwiatkowski, Nicholas, Abraham, Brian J., Lee, Tong Ihn, Xie, Shaozhen, Yuzugullu, Haluk, Von, Thanh, Li, Heyuan, Lin, Ziao, Stover, Daniel G., Lim, Elgene, Wang, Zhigang C., Iglehart, J. Dirk, Young, Richard A., Gray, Nathanael S., Zhao, Jean J.
I whakaputaina 2015Text -
10
Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells mā Wang, Yubao, Li, Young-Mi, Baitsch, Lukas, Huang, Alan, Xiang, Yi, Tong, Haoxuan, Lako, Ana, Von, Thanh, Choi, Christine, Lim, Elgene, Min, Junxia, Li, Li, Stegmeier, Frank, Schlegel, Robert, Eck, Michael J, Gray, Nathanael S, Mitchison, Timothy J, Zhao, Jean J
I whakaputaina 2018Text -
11
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation mā Li, Andrew G., Murphy, Elizabeth C., Culhane, Aedin C., Powell, Emily, Wang, Hua, Bronson, Roderick T., Von, Thanh, Giobbie-Hurder, Anita, Gelman, Rebecca S., Briggs, Kimberly J., Piwnica-Worms, Helen, Zhao, Jean J., Kung, Andrew L., Kaelin, William G., Livingston, David M.
I whakaputaina 2018Text -
12
Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer mā Gao, Xueliang, Wang, Yubao, Ribeiro, Caroline F., Manokaran, Cherubin, Chang, Hyeyoun, Von, Thanh, Rodrigues, Silvia, Cizmecioglu, Onur, Jia, Shidong, Korpal, Manav, Korn, Joshua M., Wang, Zhigang, Schmit, Fabienne, Jiang, Lan, Pagliarini, Raymond, Yang, Yi, Sethi, Isha, Signoretti, Sabina, Yuan, Guo-Cheng, Loda, Massimo, Zhao, Jean J., Roberts, Thomas M.
I whakaputaina 2022Text